Financials Photocure ASA

Equities

PHO

NO0010000045

Pharmaceuticals

Real-time Oslo Bors 05:12:25 2024-05-22 am EDT 5-day change 1st Jan Change
58.9 NOK -0.51% Intraday chart for Photocure ASA -2.16% -12.61%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,963 2,846 2,769 2,895 1,827 1,605 - -
Enterprise Value (EV) 1 1,837 2,562 2,483 2,639 1,567 1,321 1,269 1,134
P/E ratio 61.3 x -117 x -89.3 x -40.2 x 6,740 x -2,843 x 31.3 x 13.2 x
Yield - - - - - - - -
Capitalization / Revenue 6.97 x 11.1 x 7.68 x 7.73 x 4.09 x 3.23 x 2.7 x 2.27 x
EV / Revenue 6.53 x 9.99 x 6.89 x 7.05 x 3.51 x 2.65 x 2.13 x 1.61 x
EV / EBITDA 31.2 x -655 x 136 x -107 x 28.2 x 31.6 x 11.2 x 5.7 x
EV / FCF - -16.9 x 113 x -469 x 35.4 x -377 x 21.7 x 11.5 x
FCF Yield - -5.9% 0.89% -0.21% 2.82% -0.27% 4.61% 8.69%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 21,930 26,702 26,960 27,106 27,106 27,106 - -
Reference price 2 89.50 106.6 102.7 106.8 67.40 59.20 59.20 59.20
Announcement Date 2/27/20 3/3/21 2/23/22 2/23/23 2/21/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 281.6 256.5 360.5 374.5 446.2 497.5 595.4 706
EBITDA 1 58.95 -3.912 18.3 -24.63 55.49 41.74 112.8 199
EBIT 1 42.74 -23.2 -5.826 -49 27.81 23.09 82.14 166
Operating Margin 15.18% -9.05% -1.62% -13.09% 6.23% 4.64% 13.8% 23.51%
Earnings before Tax (EBT) 1 45.9 -33.23 -31.66 -71.13 9.738 5.211 65.14 156
Net income 1 31.83 -22.4 -30.9 -71.86 0.267 -0.5907 51.05 122
Net margin 11.31% -8.73% -8.57% -19.19% 0.06% -0.12% 8.57% 17.28%
EPS 2 1.460 -0.9100 -1.150 -2.660 0.0100 -0.0208 1.890 4.490
Free Cash Flow 1 - -151.2 21.99 -5.627 44.25 -3.5 58.5 98.5
FCF margin - -58.95% 6.1% -1.5% 9.92% -0.7% 9.83% 13.95%
FCF Conversion (EBITDA) - - 120.16% - 79.74% - 51.87% 49.5%
FCF Conversion (Net income) - - - - 16,573.78% - 114.59% 80.74%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/27/20 3/3/21 2/23/22 2/23/23 2/21/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2
Net sales 1 94.52 81.6 100.6 106.8 94.94 106.2 144.3 107.5 115 118 120
EBITDA 1 -5.469 -13.88 1.4 4.7 -16.87 -1.2 23.39 3.339 29.92 7.9 9
EBIT 1 -11.5 -19.88 -4.6 -1.4 -23.1 -7.7 16.84 -3.852 22.48 0.746 23
Operating Margin -12.17% -24.36% -4.57% -1.31% -24.33% -7.25% 11.67% -3.58% 19.54% 0.63% 19.17%
Earnings before Tax (EBT) 1 -33.03 -27.26 -9.053 -6.262 -28.56 -10.1 11.96 -8.666 16.55 -4.006 18
Net income 1 -28.15 -21.98 -18.46 -9.932 -21.48 -11.7 4.311 -4.788 12.48 -7.889 14
Net margin -29.78% -26.94% -18.35% -9.3% -22.63% -11.02% 2.99% -4.45% 10.85% -6.68% 11.67%
EPS -1.050 -0.8200 -0.6800 -0.3700 -0.7900 -0.4300 0.1600 -0.1800 0.4600 -0.2900 -
Dividend per Share - - - - - - - - - - -
Announcement Date 2/23/22 5/11/22 8/10/22 11/2/22 2/23/23 5/10/23 8/9/23 11/8/23 2/21/24 5/15/24 -
1NOK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 125 285 285 256 260 284 336 471
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -151 22 -5.63 44.3 -3.5 58.5 98.5
ROE (net income / shareholders' equity) 16.5% -6.25% -6.11% -14.9% 0.06% - 11.9% 26.7%
ROA (Net income/ Total Assets) - -4.34% -3.95% - 0.04% - - -
Assets 1 - 516.7 782.8 - 715.8 - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - 167 3.7 3.61 4.06 2 2.5 2.5
Capex / Sales - 65.03% 1.03% 0.96% 0.91% 0.4% 0.42% 0.35%
Announcement Date 2/27/20 3/3/21 2/23/22 2/23/23 2/21/24 - - -
1NOK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
59.2 NOK
Average target price
86 NOK
Spread / Average Target
+45.27%
Consensus
  1. Stock Market
  2. Equities
  3. PHO Stock
  4. Financials Photocure ASA
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW